Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

OTC Healthcare in Western Europe to 2011

Published by: Datamonitor

Published: Aug. 11, 2008 - 95 Pages


Table of Contents


Chapter 1 INTRODUCTION
What is this report about?
How to use this report
Market Definition
Chapter 2 OVERVIEW
Value Analysis
Chapter 3 WESTERN EUROPE OTC HEALTHCARE - MARKET OVERVIEW
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Company Share Analysis
Chapter 4 LEADING COMPANY PROFILES
GlaxoSmithKline
Pfizer Inc
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Company Share Analysis
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Company Share Analysis
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Company Share Analysis
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Company Share Analysis
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Company Share Analysis
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Company Share Analysis
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Company Share Analysis
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Company Share Analysis
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Company Share Analysis
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Company Share Analysis
Chapter 15 RESEARCH METHODOLOGY
Methodology overview
Secondary research
Market modelling
Primary research
Data finalisation
Ongoing research
Chapter 16 APPENDIX
Future readings
How to contact experts in your industry
LIST OF FIGURES
Figure 1: Western Europe OTC Healthcare value & value forecast, 2001-2011 (US$ m, nominal prices)
Figure 2: Western Europe OTC Healthcare category growth comparison, by value, 2001-2011
Figure 3: Western Europe OTC Healthcare company share (Top 5 companies), by value, 2005-2006 (%)
Figure 4: Western Europe Analgesics value & value forecast, 2001-2011 (US$ m, nominal prices)
Figure 5: Western Europe Analgesics category growth comparison, by value, 2001-2011
Figure 6: Western Europe Analgesics company share (Top 5 companies), by value, 2005-2006 (%)
Figure 7: Western Europe Cough and Cold Preparations value & value forecast, 2001-2011 (US$ m, nominal prices)
Figure 8: Western Europe Cough and Cold Preparations category growth comparison, by value, 2001-2011
Figure 9: Western Europe Cough and Cold Preparations company share (Top 5 companies), by value, 2005-2006 (%)
Figure 10: Western Europe Traditional Medicines value & value forecast, 2001-2011 (US$ m, nominal prices)
Figure 11: Western Europe Traditional Medicines company share (Top 5 companies), by value, 2005-2006 (%)
Figure 12: Western Europe First Aid Kits value & value forecast, 2001-2011 (US$ m, nominal prices)
Figure 13: Western Europe First Aid Kits company share (Top 5 companies), by value, 2005-2006 (%)
Figure 14: Western Europe Indigestion Preparations value & value forecast, 2001-2011 (US$ m, nominal prices)
Figure 15: Western Europe Indigestion Preparations category growth comparison, by value, 2001-2011
Figure 16: Western Europe Indigestion Preparations company share (Top 5 companies), by value, 2005-2006 (%)
Figure 17: Western Europe Vitamins and Minerals value & value forecast, 2001-2011 (US$ m, nominal prices)
Figure 18: Western Europe Vitamins and Minerals category growth comparison, by value, 2001-2011
Figure 19: Western Europe Vitamins and Minerals company share (Top 5 companies), by value, 2005-2006 (%)
Figure 20: Western Europe Plasters & Bandages value & value forecast, 2001-2011 (US$ m, nominal prices)
Figure 21: Western Europe Plasters & Bandages category growth comparison, by value, 2001-2011
Figure 22: Western Europe Plasters & Bandages company share (Top 5 companies), by value, 2005-2006 (%)
Figure 23: Western Europe Medicated Skin Products value & value forecast, 2001-2011 (US$ m, nominal prices)
Figure 24: Western Europe Medicated Skin Products category growth comparison, by value, 2001-2011
Figure 25: Western Europe Medicated Skin Products company share (Top 5 companies), by value, 2005-2006 (%)
Figure 26: Western Europe Other OTC Healthcare Products value & value forecast, 2001-2011 (US$ m, nominal prices)
Figure 27: Western Europe Other OTC Healthcare Products category growth comparison, by value, 2001-2011
Figure 28: Western Europe Other OTC Healthcare Products company share (Top 5 companies), by value, 2005-2006 (%)
Figure 29: Western Europe Topical OTC Medicines value & value forecast, 2001-2011 (US$ m, nominal prices)
Figure 30: Western Europe Topical OTC Medicines category growth comparison, by value, 2001-2011
Figure 31: Western Europe Topical OTC Medicines company share (Top 5 companies), by value, 2005-2006 (%)
Figure 32: Annual data review process
LIST OF TABLES
Table 1: OTC Healthcare category definitions
Table 2: Western Europe OTC Healthcare value (country-wise), 2001-2006 (US$ m, nominal prices)
Table 3: Western Europe OTC Healthcare value (country-wise) forecast, 2006-2011 (US$ m, nominal prices)
Table 4: Western Europe OTC Healthcare value, 2001-2006 (US$ m, nominal prices)
Table 5: Western Europe OTC Healthcare value forecast, 2006-2011 (US$ m, nominal prices)
Table 6: Western Europe OTC Healthcare company share (Top 20 Companies) by value, 2005-2006 (%)
Table 7: Western Europe OTC Healthcare value, by company, 2005-2006 (US$ m nominal prices)
Table 8: GlaxoSmithKline Key Facts
Table 9: Pfizer Inc Key Facts
Table 10: Western Europe Analgesics value, 2001-2006 (US$ m, nominal prices)
Table 11: Western Europe Analgesics value forecast, 2006-2011 (US$ m, nominal prices)
Table 12: Western Europe Analgesics company share (Top 20 Companies) by value, 2005-2006 (%)
Table 13: Western Europe Analgesics value, by company, 2005-2006 (US$ m nominal prices)
Table 14: Western Europe Cough and Cold Preparations value, 2001-2006 (US$ m, nominal prices)
Table 15: Western Europe Cough and cold preparations value forecast, 2006-2011 (US$ m, nominal prices)
Table 16: Western Europe Cough and Cold Preparations company share (Top 20 Companies) by value, 2005-2006 (%)
Table 17: Western Europe Cough and Cold Preparations value, by company, 2005-2006 (US$ m nominal prices)
Table 18: Western Europe Traditional Medicines value, 2001-2006 (US$ m, nominal prices)
Table 19: Western Europe Traditional Medicines value forecast, 2006-2011 (US$ m, nominal prices)
Table 20: Western Europe Traditional Medicines company share (Top 20 Companies) by value, 2005-2006 (%)
Table 21: Western Europe Traditional Medicines value, by company, 2005-2006 (US$ m nominal prices)
Table 22: Western Europe First Aid Kits value, 2001-2006 (US$ m, nominal prices)
Table 23: Western Europe First Aid Kits value forecast, 2006-2011 (US$ m, nominal prices)
Table 24: Western Europe First Aid Kits company share (Top 20 Companies) by value, 2005-2006 (%)
Table 25: Western Europe First Aid Kits value, by company, 2005-2006 (US$ m nominal prices)
Table 26: Western Europe Indigestion Preparations value, 2001-2006 (US$ m, nominal prices)
Table 27: Western Europe Indigestion Preparations value forecast, 2006-2011 (US$ m, nominal prices)
Table 28: Western Europe Indigestion Preparations company share (Top 20 Companies) by value, 2005-2006 (%)
Table 29: Western Europe Indigestion Preparations value, by company, 2005-2006 (US$ m nominal prices)
Table 30: Western Europe Vitamins and Minerals value, 2001-2006 (US$ m, nominal prices)
Table 31: Western Europe Vitamins and Minerals value forecast, 2006-2011 (US$ m, nominal prices)
Table 32: Western Europe Vitamins and Minerals company share (Top 20 Companies) by value, 2005-2006 (%)
Table 33: Western Europe Vitamins and Minerals value, by company, 2005-2006 (US$ m nominal prices)
Table 34: Western Europe Plasters & Bandages value, 2001-2006 (US$ m, nominal prices)
Table 35: Western Europe Plasters & Bandages value forecast, 2006-2011 (US$ m, nominal prices)
Table 36: Western Europe Plasters & Bandages company share (Top 20 Companies) by value, 2005-2006 (%)
Table 37: Western Europe Plasters & Bandages value, by company, 2005-2006 (US$ m nominal prices)
Table 38: Western Europe Medicated Skin Products value, 2001-2006 (US$ m, nominal prices)
Table 39: Western Europe Medicated Skin Products value forecast, 2006-2011 (US$ m, nominal prices)
Table 40: Western Europe Medicated Skin Products company share (Top 20 Companies) by value, 2005-2006 (%)
Table 41: Western Europe Medicated Skin Products value, by company, 2005-2006 (US$ m nominal prices)
Table 42: Western Europe Other OTC Healthcare Products value, 2001-2006 (US$ m, nominal prices)
Table 43: Western Europe Other OTC Healthcare Products value forecast, 2006-2011 (US$ m, nominal prices)
Table 44: Western Europe Other OTC Healthcare Products company share (Top 20 Companies) by value, 2005-2006 (%)
Table 45: Western Europe Other OTC Healthcare Products value, by company, 2005-2006 (US$ m nominal prices)
Table 46: Western Europe Topical OTC Medicines value, 2001-2006 (US$ m, nominal prices)
Table 47: Western Europe Topical OTC Medicines value forecast, 2006-2011 (US$ m, nominal prices)
Table 48: Western Europe Topical OTC Medicines company share (Top 20 Companies) by value, 2005-2006 (%)
Table 49: Western Europe Topical OTC Medicines value, by company, 2005-2006 (US$ m nominal prices)

Abstract

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in Western Europe. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011 for 17 countries covered within the Western Europe region.

Scope
  • Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
  • Provides market value, volume data by market, segment and sub segment
Highlights

The Western Europe OTC Healthcare market covering 17 countries, increased between 2001-2006, growing at an average annual rate of 2.3%.

The leading company in the market in 2006 was GlaxoSmithKline Plc. The second-largest player was Pfizer Inc with Bayer AG is third place.

Reasons to Purchase
  • Discover the major quantitative trends affecting the OTC Healthcare markets
  • Understand consumers' consumption and expenditure patterns for the 17 countries covered
  • Understand the future direction of the market with reliable historical data and full five year forecasting


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2012
2/15/2012 - 32